Navigation Links
Ocera Therapeutics receives CE Mark for Zysa™ for the treatment of diarrhea-predominant Irritable Bowel Syndrome (IBS-d)
Date:5/18/2012

al carbon adsorbent with a selective adsorption profile for a variety of substances linked to IBS-d. Zysa also adsorbs other substances including ammonia, indoles (serotonin), histamine, bile acids, advanced glycation endproducts (AGE), and certain bacterial toxins. Ocera licensed the compound from Kureha Corporation (Japan). Zysa has been used chronically by over 360,000 patients and studied in over 3,000 patients worldwide. It is marketed as Kremezin™ in Asia.

About Ocera Therapeutics, Inc.
Ocera Therapeutics, based in San Diego, California, USA, is a privately-held biopharmaceutical company focused on the development and commercialization of proprietary compounds to treat liver diseases and gastrointestinal disorders.  In addition to Zysa™ (spherical carbon adsorbent), Ocera is developing OCR-002, an ammonia detoxification agent, for the treatment of patients with hepatic encephalopathy and acute liver failure. Ocera has raised over $60 million in financing from Domain Associates, Sofinnova Ventures, Thomas, McNerney & Partners, Greenspring Global Partners and InterWest Partners. Additional information on the company can be found at www.oceratherapeutics.com.


'/>"/>
SOURCE Ocera Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohns Disease
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
4. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
5. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
8. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
11. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015 OpportunityAnalyzer: Sepsis - ... Sepsis patients suffer from a series of diverse complications ... in the blood or tissues, which cause a rapidly ... to mortality rates near 50% depending on disease severity. ... healthcare systems of the global marketplace, which for the ...
(Date:5/27/2015)... 27, 2015 Protein purification involves the process ... in their physical properties. The objective of a protein ... functional protein with fewest contaminants. The global protein purification ... CAGR of around 5% to 6% during the forecast ... in the pharmaceutical and biotechnological fields, growing need to ...
(Date:5/27/2015)... DUBLIN , May 27, 2015 /PRNewswire/ ... Markets ( http://www.researchandmarkets.com/research/bnrjw5/2015_strategies ) has announced the addition ... Nucleic Acid Testing Market"  report to ... ,  , ,Major issues pertaining to the ... key economic, regulatory, demographic, social and technological ...
Breaking Medicine Technology:OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 2OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 3OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 4Protein Purification & Isolation Market by Technology by Product by Application & End User - Global Forecast to 2020 2Protein Purification & Isolation Market by Technology by Product by Application & End User - Global Forecast to 2020 3United States Nucleic Acid Testing Market Strategies 2015-2020 2
... 28 Warner Chilcott plc (Nasdaq: WCRX ) ... Par Pharmaceutical, Inc. ("Par").  The Paragraph IV Certification Notice advises the Company ... for a generic version of the Company,s ASACOL 400 mg delayed release ... ASACOL 400 ...
... ANTONY, France , June 28, 2010 ... IIb/III clinical,trial (VO 57.07) conducted on Actair(R) sublingual allergen immunotherapy,tablets in allergic ... today announces the results of the second year of this,study. , ... Following this ...
Cached Medicine Technology:Warner Chilcott Announces Receipt of Paragraph IV Certification Notice 2Warner Chilcott Announces Receipt of Paragraph IV Certification Notice 3STALLERGENES: Persistent Efficacy Demonstrated After a Year on Actair(R) Followed by a Second Treatment-Free Year 2STALLERGENES: Persistent Efficacy Demonstrated After a Year on Actair(R) Followed by a Second Treatment-Free Year 3STALLERGENES: Persistent Efficacy Demonstrated After a Year on Actair(R) Followed by a Second Treatment-Free Year 4
(Date:5/28/2015)... (PRWEB) May 28, 2015 Dallas ... updated version of his patient education website ... redesign allows patients to readily access current educational ... dysfunction treatment, male urinary incontinence, prostate cancer treatment, ... of this website is to educate patients on ...
(Date:5/28/2015)... Portland, Ore. (PRWEB) May 28, 2015 ... announced today that it has been named a “Cool ... titled Cool Vendors in Healthcare Payers, 2015 ... J. Lheureux. The report highlights innovative vendors, products and ... into new trends in the health care payer market. ...
(Date:5/28/2015)... Sunshine Coast Health Center, one of ... at http://www.sunshinecoasthealthcentre.ca , is proud to announce ... the Toronto, Ontario, community. The company has a ... its online location information for Toronto residents. , ... we realize that addiction impacts family and friends," ...
(Date:5/28/2015)... 2015 The Cancer Solution: Taking Charge ... rewarding, researched and heartfelt book the Booksandauthor reviewer ... Westman for writing what should be one of the ... and there is power in action and this book has ... wants to talk about and unfortunately many persons know little ...
(Date:5/28/2015)... JJ Mowder-Tinney, PT, PhD, NCS, C/NDT, CSRS ... Physical Therapy Association (NYPTA) by the Delegation at their Delegate ... the NYPTA. At the National level, she was a ... Committee and an abstract reviewer for the Neurology Section Research ... member of the Program committee since 2010 and has held ...
Breaking Medicine News(10 mins):Health News:Mark Allen MD, Dallas Urologist, Launches Updated Patient Education Website With a Focus on Prostate Cancer and Erectile Dysfunction Treatment 2Health News:SpendWell Named a “Cool Vendor” by Gartner 2Health News:SpendWell Named a “Cool Vendor” by Gartner 3Health News:SpendWell Named a “Cool Vendor” by Gartner 4Health News:Toronto Alcohol Treatment and Drug Rehab Local Information Page Updated, Announces Sunshine Coast Health Center 2Health News:Toronto Alcohol Treatment and Drug Rehab Local Information Page Updated, Announces Sunshine Coast Health Center 3Health News:Booksandauthor Cites The Cancer Solution as One of the Most Important Books to Read 2
... hormonal changes, study found , WEDNESDAY, Sept. 5 (HealthDay ... post-traumatic stress disorder (PTSD) often experience the biological signs ... stress hormone cortisol, researchers report. , The research involved ... , A team of researchers from the Mount Sinai ...
... scientists say , , WEDNESDAY, Sept. 5 (HealthDay News) -- Two ... of them also increases the odds for lupus, according to ... the gene called STAT4 is one of the ... rheumatoid arthritis or lupus, both of which are autoimmune disorders, ...
... The National Association for Sport,and Physical Education ... to help to educate, challenge, and encourage all ... a healthy and fit life. As,the new sponsor ... Worldwide,will assist the nonprofit education association in promoting ...
... individual to a children,s hospital nationally, CHICAGO, Sept. ... Lurie has pledged $100 million to help fund,the new ... is the largest given by an individual to a ... gift, the largest charitable investment received in,the hospital,s 125-year ...
... 5 The Health Industry,Distributors Association (HIDA) announces ... structure by which administrative fees charged by group,purchasing ... products,distributors. "HIDA is calling for discussion on ... the fee structure for medical products distributors in,line ...
... Medical,Outsourcing announced today the appointment of Shawn Martin ... facility. With expertise as a,Distribution Supervisor for DePuy ... of experience as a former Captain in the ... development of Millstone,s new,Memphis service center, which will ...
Cached Medicine News:Health News:Parents' PTSD May Boost Stress in Offspring 2Health News:Genes Boost Risk for Rheumatoid Arthritis, Lupus 2Health News:Genes Boost Risk for Rheumatoid Arthritis, Lupus 3Health News:Genes Boost Risk for Rheumatoid Arthritis, Lupus 4Health News:National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Children's Fitness 2Health News:National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Children's Fitness 3Health News:Children's Memorial Hospital in Chicago Announces $100 Million Gift from Philanthropist Ann Lurie 2Health News:Children's Memorial Hospital in Chicago Announces $100 Million Gift from Philanthropist Ann Lurie 3Health News:HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure 2Health News:Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility 2Health News:Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility 3
... Atlas Eclipse model 995 is ... It offers ultra-low illumination and ... model 995 is ideal for ... lens specialists who require comprehensive ...
... is a corneal topographer that gives ... for refractive surgery, contact lens fitting ... fitting in a small 8.5" tall ... you need to supply is the ...
The only ergonomic work station of its kind with an optional built-in keratograph and flat-screen. The Concepta is a modern workstation for the examination and refraction of patients....
The natural look of 3 in 1 technology in virtually any prescription....
Medicine Products: